GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE139070 Query DataSets for GSE139070
Status Public on Jun 23, 2021
Title RNA-seq analysis of human pancreas cell line SU8686 treated with DOT1L inhibitor (SGC0946) or DMSO
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary To understand the pathway alteration associated with DOT1L inhibition, we performed RNA-seq analysis of DOT1L inhibitor treated human pancreas cell line SU8686. We reported the changed pathways.
Overall design The SU8686 cells were treated with 20 μM SGC0946 or DMSO for 72 hr (triplicate)
Contributor(s) Liu Z, Liu Y, Qian L, Jiang S, Gai X, Ye S, Chen Y, Wang X, Zhai L, Xu J, Pu C, Li J, He F, Huang M, Tan M
Citation(s) 34375582
Submission date Oct 18, 2019
Last update date Sep 22, 2021
Contact name Zhiwei Liu
Organization name Chinese Academy of Sciences
Street address Zuchongzhi Road 555
City Shanghai
ZIP/Postal code 201203
Country China
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (6)
GSM4128661 RNA-seq_DMSO 1
GSM4128662 RNA-seq_DMSO 2
GSM4128663 RNA-seq_DMSO 3
BioProject PRJNA578266
SRA SRP226165

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE139070_transcript.fpkm.matrix.annot.xls.gz 21.4 Mb (ftp)(http) XLS
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap